NXGN News and Press, NextGen Healthcare Inc. From 11/04/21

NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced that President and Chief Executive Officer, David Sides, and Chief Financial Officer, Jamie Arnold, will participate in the upcoming virtual investor conferences: ...

Prestigious Ophthalmic Practice Center in Southern U.S. Leverages NextGen® Enterprise EHR with NextGen® Mobile to Improve Practice Efficiency and Patient Access NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutio...

Company’s Sixth Time Winning Coveted Award Honoring Healthcare Leaders Making Improvements to Prescription Accuracy NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced that it is a...

Cantor Fitzgerald has lifted the price target of NextGen Healthcare (NXGN +7.7%) after the company reported better-than-expected revenue and adj. earnings for Q2 fiscal 2022. Maintaining the Overweight rating on the stock, the analyst Steven Halper points to its undervaluation despite th...

Image source: The Motley Fool. NextGen Healthcare, Inc (NASDAQ: NXGN) Q2 2022 Earnings Call Oct 28, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: NextGen Healthcare, Inc (NXGN) Q2 2022 Earnings Call Transcript

NextGen Healthcare, Inc. (NXGN) Q2 2022 Earnings Conference Call October 28, 2021, 05:00 PM ET Company Participants Matt Scalo - Vice President, Investor Relations David Sides - President and Chief Executive Officer Jamie Arnold - Executive Vice President and Chief Financial Officer Conferenc...

NextGen Healthcare (NASDAQ:NXGN): Q3 Non-GAAP EPS of $0.29 beats by $0.06; GAAP EPS of -$0.10 misses by $0.16. Revenue of $149.29M (+6.6% Y/Y) beats by $5.82M. Shares +1.33%. Press Release For further details see: NextGen Healthcare EPS beats by $0.06, beats on revenue

NextGen Healthcare (NASDAQ:NXGN) has authorized a share repurchase program for up to $60M through March 2023. The company currently has approximately 67 million shares outstanding. "We believe that the share repurchase program announced today represents an appropriate and strategic use o...

NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced that its Board of Directors has authorized a share repurchase program under which the Company may repurchase up to $60 million of its outstanding shares of common ...

Raises Fiscal 2022 Financial Guidance NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced its operating results for the fiscal second quarter ended September 30, 2021. Fiscal 2022 Second Quarte...